BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1591717)

  • 1. Polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose in combination with interleukin 2 in patients with cancer: clinical and immunological effects.
    Ewel CH; Urba WJ; Kopp WC; Smith JW; Steis RG; Rossio JL; Longo DL; Jones MJ; Alvord WG; Pinsky CM
    Cancer Res; 1992 Jun; 52(11):3005-10. PubMed ID: 1591717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma.
    Okada H; Kalinski P; Ueda R; Hoji A; Kohanbash G; Donegan TE; Mintz AH; Engh JA; Bartlett DL; Brown CK; Zeh H; Holtzman MP; Reinhart TA; Whiteside TL; Butterfield LH; Hamilton RL; Potter DM; Pollack IF; Salazar AM; Lieberman FS
    J Clin Oncol; 2011 Jan; 29(3):330-6. PubMed ID: 21149657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of advanced ovarian cancer with polyinosinic-polycytidylic lysine carboxymethylcellulose (poly(ICLC)).
    Rettenmaier MA; Berman ML; DiSaia PJ
    Gynecol Oncol; 1986 Jul; 24(3):359-61. PubMed ID: 3721308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I trials of poly(I,C) complexes in advanced cancer.
    Krown SE; Kerr D; Stewart WE; Field AK; Oettgen HF
    J Biol Response Mod; 1985 Dec; 4(6):640-9. PubMed ID: 2418162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Immune Modulation against Solid Cancers with Intratumoral Poly-ICLC: A Pilot Trial.
    Kyi C; Roudko V; Sabado R; Saenger Y; Loging W; Mandeli J; Thin TH; Lehrer D; Donovan M; Posner M; Misiukiewicz K; Greenbaum B; Salazar A; Friedlander P; Bhardwaj N
    Clin Cancer Res; 2018 Oct; 24(20):4937-4948. PubMed ID: 29950349
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyporeactivity to interferon induction in newborn piglets.
    Derbyshire JB; Lesnick CE
    J Interferon Res; 1990 Feb; 10(1):47-53. PubMed ID: 1691769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune response modifying activity in mice of polyinosinic: polycytidylic acid stabilized with poly-L-lysine, in carboxymethylcellulose [poly-ICLC].
    Chirigos MA; Papademetriou V; Bartocci A; Read E; Levy HB
    Int J Immunopharmacol; 1981; 3(4):329-37. PubMed ID: 7333719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: a North American Brain Tumor Consortium (NABTC01-05).
    Butowski N; Chang SM; Junck L; DeAngelis LM; Abrey L; Fink K; Cloughesy T; Lamborn KR; Salazar AM; Prados MD
    J Neurooncol; 2009 Jan; 91(2):175-82. PubMed ID: 18797818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of natural killer cells in newborn piglets by interferon induction.
    Lesnick CE; Derbyshire JB
    Vet Immunol Immunopathol; 1988 Mar; 18(2):109-17. PubMed ID: 2838948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly ICLC inhibits Plasmodium cynomolgi B malaria infection in rhesus monkeys.
    Puri SK; Dutta GP; Levy HB; Maheshwari RK
    J Interferon Cytokine Res; 1996 Jan; 16(1):49-52. PubMed ID: 8640451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of interferon inducer (poly ICLC) in the treatment of malignant brain tumor (author's transl)].
    Nakamura O; Shitara N; Matsutani M; Takakura K; Machida H
    No To Shinkei; 1982 Mar; 34(3):267-73. PubMed ID: 7093065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification of carboxymethylcellulose decreases toxicity of poly ICLC in mice.
    Bello J; O'Malley J; Granados E
    J Interferon Res; 1985; 5(3):429-30. PubMed ID: 4056490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon induction in piglets with polyinosinic:polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose.
    Loewen KG; Derbyshire JB
    Res Vet Sci; 1988 Jan; 44(1):132-3. PubMed ID: 2453906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term treatment of malignant gliomas with intramuscularly administered polyinosinic-polycytidylic acid stabilized with polylysine and carboxymethylcellulose: an open pilot study.
    Salazar AM; Levy HB; Ondra S; Kende M; Scherokman B; Brown D; Mena H; Martin N; Schwab K; Donovan D; Dougherty D; Pulliam M; Ippolito M; Graves M; Brown H; Ommaya A
    Neurosurgery; 1996 Jun; 38(6):1096-103; discussion 1103-4. PubMed ID: 8727138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose and regimen effects of poly ICLC, an interferon inducer, in a multi-dose bleomycin model of interstitial pulmonary fibrosis.
    Wild JS; Hyde DM; Giri SN
    Pharmacol Toxicol; 1994 Jul; 75(1):42-8. PubMed ID: 7526360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A North American brain tumor consortium phase II study of poly-ICLC for adult patients with recurrent anaplastic gliomas.
    Butowski N; Lamborn KR; Lee BL; Prados MD; Cloughesy T; DeAngelis LM; Abrey L; Fink K; Lieberman F; Mehta M; Ian Robins H; Junck L; Salazar AM; Chang SM
    J Neurooncol; 2009 Jan; 91(2):183-9. PubMed ID: 18850068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and antibody immune response of CHP-NY-ESO-1 vaccine combined with poly-ICLC in advanced or recurrent esophageal cancer patients.
    Ishikawa T; Kageyama S; Miyahara Y; Okayama T; Kokura S; Wang L; Sato E; Yagita H; Itoh Y; Shiku H
    Cancer Immunol Immunother; 2021 Nov; 70(11):3081-3091. PubMed ID: 33751208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase I evaluation of poly(I,C)-LC in cancer patients.
    Stevenson HC; Abrams PG; Schoenberger CS; Smalley RB; Herberman RB; Foon KA
    J Biol Response Mod; 1985 Dec; 4(6):650-5. PubMed ID: 2418163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review on poly(I:C) and poly-ICLC in glioblastoma: adjuvants coordinating the unlocking of immunotherapy.
    De Waele J; Verhezen T; van der Heijden S; Berneman ZN; Peeters M; Lardon F; Wouters A; Smits ELJM
    J Exp Clin Cancer Res; 2021 Jun; 40(1):213. PubMed ID: 34172082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Killing of Leishmania donovani amastigotes by poly ICLC in hamsters.
    Bhakuni V; Singha UK; Dutta GP; Levy HB; Maheshwari RK
    J Interferon Cytokine Res; 1996 Apr; 16(4):321-5. PubMed ID: 9162526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.